Clyburn Frank
SEC-identified person · CIK 1763963 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Revolution Medicines, Inc. RVMD | Director | filed 2024 - 2026 |
| Kailera Therapeutics, Inc. KLRA | Director | filed 2026 - 2026 |
| Cencora, Inc. COR | Director | filed 2024 - 2026 |
| International Flavors & Fragrances INC IFF | Chief Executive Officer | filed 2022 - 2024 |
| Schering Plough Corp SGP | EVP, Chief Commercial Officer | filed 2019 - 2021 |
| Dupont de Nemours, Inc. DWDP | Director | filed 2019 - 2021 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.